ASSESSMENT OF THE IMMUNOGENICITY AND SAFETY OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH RHEUMATIC DISEASES

ASSESSMENT OF THE IMMUNOGENICITY AND SAFETY OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH RHEUMATIC DISEASES

Objective: to investigate the immunogenicity and safety of 23-valent polysaccharide pneumococcal vaccine in patients with rheumatic diseases (RD).Subjects and methods. The prospective open-label comparative study enrolled 133 people (102 (76.7%) women and 31 (23.3%) men) aged 23 to 76 years, includi...

Full description

Bibliographic Details
Main Authors: M. S. Naumtseva, B. S. Belov, E. N. Aleksandrova, G. M. Tarasova, A. A. Novikov, D. E. Karateev, E. L. Luchikhina, A. V. Volkov, N. N. Yudkina, O. A. Antelava, A. N. Khelkovskaya-Sergeeva, M. V. Cherkasova, Yu. V. Muravyev
Format: Article
Language:Russian
Published: IMA PRESS LLC 2016-02-01
Series:Научно-практическая ревматология
Subjects:
rheumatoid arthritis
autoimmune diseases
pneumonia
bronchitis
pneumococcal vaccine
vaccination
coinfections
comorbidity
immunogenicity
efficacy
tolerability
Online Access:https://rsp.mediar-press.net/rsp/article/view/2147

Internet

https://rsp.mediar-press.net/rsp/article/view/2147

Similar Items